Business & Finance
Chinese Biotech Overtakes AI as Emerging-Market Growth Trade
Key Points
Chinese Biotech Overtakes AI as Emerging-Market Growth Trade As the artificial-intelligence rally sputters in emerging markets, investors searching for high-growth alternatives are turning to Chinese biotech. Bloomberg’s EM technology index has tumbled into a bear market over the past month as SK Hynix Inc. and Samsung Electronics Co., the poster children of the AI boom, slumped 40% and 29%, respectively.
Chinese Biotech Overtakes AI as Emerging-Market Growth Trade
As the artificial-intelligence rally sputters in emerging markets, investors searching for high-growth alternatives are turning to Chinese biotech.
Bloomberg’s EM technology index has tumbled into a bear market over the past month as SK Hynix Inc. and Samsung Electronics Co., the poster children of the AI boom, slumped 40% and 29%, respectively. By contrast, at least 10 Chinese pharmaceutical stocks have posted double-digit gains, making healthcare the best-performing sector in Bloomberg’s emerging-market benchmark.